1.Hatfaludi T, Al-Hasani K, Dunstone M, Boyce J, Adler B.. (2008) Characterization of TolC efflux pump proteins from Pasteurella multocida., 52 (11):[PMID:18725450][10.1128/aac.00245-08]
2.Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1):[PMID:20014752][10.1021/tx900326k]
3.Unpublished dataset,
4.USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date,
5.Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22):[PMID:23062825][10.1016/j.bmc.2012.09.040]
6.De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6):[PMID:23571415][10.1124/mol.112.084152]
7.British National Formulary (72nd edition),
8.Unpublished dataset,
9.Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846]
